DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages.
First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Competitive Assessment of Transdermal Drugs Delivery Market
08. Optimisation of Transdermal Drug Delivery
09. Market Segmentation by Application
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
Companies Mentioned:
- ANI Pharmaceuticals Inc.
- Antares Pharma Inc.
- Bayer AG
- Janssen Pharmaceuticals Inc.
- Novartis AG
- 3M Pharmaceuticals Co.
- Durect Corp.
- Iontera Inc.
- Isis Biopolymer Inc.
- LTS Lohmann Therapie-Systeme AG
- Mylan Laboratories Inc.
- Nitto Denko Corp.
- Pantec Biosolutions AG
- Phosphagenics Ltd.
- Tesa Labtec GmbH
- Teva Pharmaceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/research/dj2pc6/global
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
